In our setting, it is quite common that control of major risk factors of patients with type 2 diabetes (T2D) after myocardial infarction (MI) is not made by specific risk factors units (SRFU). Here, we conducted a preliminary study to investigate the effects of a SRFU intervention on metabolic and cardiovascular outcomes in T2D patients who suffered from MI.
Introduction

Methods/ Design
This retrospective and observational study was performed in one single centre. Data related to metabolic and cardiologic variables were collected at discharge and at 6 and 12 months of follow-up. Variables were compared according to whether risk factors control was made by SRFU or other specialties after discharge.
Conclusions
Our results show a non-significant trend toward to improvement of metabolic and cardiovascular outcomes among patients that were referred to SRFU after MI.
These differences were more remarkable when follow-up time was longer.
Though further studies with a larger number of patients are ongoing in our Hospital, we conclude that referrals to a SRFU should be recommended in these patients.
Results
Data from forty-eight patients were collected. Demographic and clinical data are summarized in TABLE 1.
27.5% were referred to SRFU after discharge. Antidiabetic treatment was changed in 48.7%. Among patients whose treatment was changed, add-on strategy was the most used way to switch it (63.2%). Patients referred to SRFU were more likely to undergo changes in treatment (81.8% vs 35.7%; p = 0.01). A1C reductions were higher among patients under SRFU control at 6 and one year and rates of new hospitalizations due to heart failure as well as mortality by any cause were lower in SRFU group. Nevertheless, non-significant differences were observed between groups (TABLE 2). Non significant differences were observed between units at 6 and at 12 months.
